H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site

Muhammad Yusuf1, Nornisah Mohamed1, Suriyati Mohamad1,2

  • 1Pharmaceutical Design and Simulation (PhDS) Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia , 11800 Minden, Pulau Pinang, Malaysia.

Insights

Oseltamivir resistance in influenza emerges from the H274Y mutation in neuraminidase (NA). This mutation disrupts the NA binding site, compromising drug efficacy and impacting anti-influenza drug design.

Area of Science:

  • Virology
  • Structural Biology
  • Drug Discovery

Background:

  • Oseltamivir (OTV) resistance in influenza viruses is a growing concern, particularly strains with the H274Y mutation in neuraminidase (NA).
  • Previous studies on H274Y resistance primarily focused on drug-bound states, leaving the mutation's intrinsic effects on NA structure unclear.

Purpose of the Study:

  • To investigate the direct structural impact of the H274Y mutation on the NA binding site in the absence of the drug.
  • To elucidate the mechanism by which the H274Y mutation affects OTV binding and resistance.

Main Methods:

  • Molecular dynamics simulations of NA in apo form.
  • Principal component analysis (PCA) and interaction energy calculations.
  • Sliding box docking simulations.

Main Results:

  • The H274Y mutation disrupts the NA binding site, initiated by a repulsive effect on the 250-loop and altered hydrogen bonding.
  • The mutation causes conformational changes, including the rotation of W295 and upward movement of the 340-loop.
  • These structural changes compromise the binding pathway for OTV, suggesting reduced drug efficacy.

Conclusions:

  • The H274Y mutation intrinsically alters NA structure, leading to OTV resistance.
  • Understanding these structural changes is crucial for designing next-generation anti-influenza drugs.
  • The C6 functional group of sialic acid mimics is important for drug interaction.

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
37
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.7K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.9K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.1K